Nanoparticle-Based Ethinylestradiol Patch
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Transdermal
-
Intended Duration:
- Not Yet Determined
- Development Stage: Discovery & Early Development
- Developer(s)/researcher(s): University of Veterinary and Animals Sciences Lahore, Mirpur University of Science and Technology
Details
- API: Ethinylestradiol
- Target: Estrogen Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Inactive Materials: Eudragit-Based Polymeric Films
- Regimen: Not Yet Determined
- MPT: Not Potential MPT
- Promising Attributes: Not Yet Established - Concept is in Early Development
Product Status
Active/Recent Early Development
History
2023: Researchers publish results of evaluation of a nanoparticle-based transdermal drug delivery system, documenting folding endurance, drug content, yield, entrapment efficiency, in vitro release pattern, FTIR, and DSC, as well as the results of accelerated stability studies. The products were found to have favorable release profiles, highly efficient drug loading and yield, and stability at 40C and 70% humidity over 6 months.